Treatment of paediatric acute lymphoblastic leukaemia with a modified
resource-conserved BFM protocol in Kosovo: Monitoring outcome
using minimal residual disease evaluation by flow cytometry and
evaluation of toxicity and costs – surveillance of the achieved
success for a safe future!